selected publications
-
academic article
-
Change and dispersion of QT interval during treatment with quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: results from the TEA trial.
Psychopharmacology.
235.
2018
Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial.
BMJ Open.
8.
2018
Eosinopenia in women with schizophrenia: Drug-induced or a sign of gender specific difference in pathogenesis?.
Schizophrenia Research.
197.
2018
Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey nucleus accumbens.
Scientific Reports.
8.
2018
Ketogenic Diet Suppresses Alcohol Withdrawal Syndrome in Rats.
Alcoholism Clinical and Experimental Research.
42.
2018
PICK1-Deficient Mice Exhibit Impaired Response to Cocaine and Dysregulated Dopamine Homeostasis.
eNeuro.
5.
2018
Prospective psychometric characterization of hip and knee arthroplasty patients.
Nordic Journal of Psychiatry.
72.
2018
Substance use among Danish psychiatric patients: a cross-sectional study.
Nordic Journal of Psychiatry.
72.
2018
Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis.
Journal of the American Academy of Child & Adolescent Psychiatry.
56.
2017
Adverse events in children and adolescents treated with quetiapine.
International Clinical Psychopharmacology.
32.
2017
Antipsychotic treatment of schizotypy and schizotypal personality disorder: a systematic review.
Journal of Psychopharmacology.
31.
2017
Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial.
JAMA Psychiatry.
74.
2017
Effects of Prenatal Alcohol Exposure on the Visual System of Monkeys Measured at Different Stages of Development.
Investigative Ophthalmology & Visual Science.
58.
2017
Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain—Reply.
JAMA Psychiatry.
74.
2017
Muscarinic receptor M4 positive allosteric modulators attenuate central effects of cocaine.
Drug and Alcohol Dependence.
176.
2017
Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial..
The Journal of Clinical Psychiatry.
78.
2017
Psychopharmacologic treatment and blood transfusion in fast‐track total hip and knee arthroplasty.
Transfusion.
57.
2017
Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
The Lancet Psychiatry.
4.
2017
Sudden Cardiac Death Pharmacotherapy and Proarrhythmic Drugs: A Nationwide Cohort Study in Denmark.
JACC Clinical Electrophysiology.
3.
2017
The Role of Psychiatric Diagnoses for Outcome After Hip and Knee Arthroplasty.
The Journal of Arthroplasty.
32.
2017
The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice.
Pharmacology Biochemistry and Behavior.
160.
2017
The relationship between self-reported childhood adversities, adulthood psychopathology and psychological stress markers in patients with schizophrenia.
Comprehensive Psychiatry.
72.
2017
The significance of sampling time in therapeutic drug monitoring of clozapine.
Acta Psychiatrica Scandinavica.
135.
2017
4.17 QUETIAPINE EXTENDED RELEASE VERSUS ARIPIPRAZOLE IN CHILDREN AND ADOLESCENTS WITH PSYCHOSIS IN THE RANDOMIZED, BLINDED CLINICAL TOLERABILITY AND EFFICACY OF ANTIPSYCHOTICS (TEA) TRIAL.
Journal of the American Academy of Child & Adolescent Psychiatry.
55.
2016
Alcohol consumption among patients with diabetes: a survey-based cross-sectional study of Danish adults with diabetes.
Scandinavian Journal of Public Health.
44.
2016
Clinical Characteristics and Predictors of Outcome of Schizophrenia-Spectrum Psychosis in Children and Adolescents: A Systematic Review.
Journal of Child and Adolescent Psychopharmacology.
26.
2016
Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels.
Translational Psychiatry.
6.
2016
Glucagon-like peptide-1 (GLP-1) analogues: A potential new treatment for alcohol use disorder?.
Nordic Journal of Psychiatry.
70.
2016
Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
Journal of Clinical Psychopharmacology.
36.
2016
Phenobarbital compared to benzodiazepines in alcohol withdrawal treatment: A register-based cohort study of subsequent benzodiazepine use, alcohol recidivism and mortality.
Drug and Alcohol Dependence.
161.
2016
Psychiatric disease as a risk factor in fast-track hip and knee replacement.
Acta Orthopaedica.
87.
2016
Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression.
Acta Psychiatrica Scandinavica.
133.
2016
Treatment of adult patients with schizophrenia and complex mental health needs – A national clinical guideline.
Nordic Journal of Psychiatry.
70.
2016
Antipsychotic-Like Effect of the Muscarinic Acetylcholine Receptor Agonist BuTAC in Non-Human Primates.
PLoS ONE.
10.
2015
Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case–control study.
BMC Psychiatry.
15.
2015
Corrected QT Changes During Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials.
Journal of the American Academy of Child & Adolescent Psychiatry.
54.
2015
Enhanced self-administration of alcohol in muscarinic acetylcholine M4 receptor knockout mice.
European Journal of Pharmacology.
746.
2015
P-49INACTIVATION OF THE CHOLINERGIC M4 RECEPTOR RESULTS IN THE DEVELOPMENT OF A LOW ANXIETY ENDOPHENOTYPE PREDICTING FUTURE ALCOHOL CONSUMPTION.
Alcohol and Alcoholism.
50.
2015
SY15-2SUBCHRONIC LOW DOSE EXENDIN-4 PRETREATMENT INHIBITS RELAPSE TO ALCOHOL DRINKING IN HIGH ALCOHOL PREFERING C57BL6 MICE.
Alcohol and Alcoholism.
50.
2015
Sudden cardiac death in young adults with previous hospital-based psychiatric inpatient and outpatient treatment: a nationwide cohort study from Denmark..
The Journal of Clinical Psychiatry.
76.
2015
The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice.
Physiology & Behavior.
149.
2015
Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials.
BMJ Open.
4.
2014
Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial.
BMJ Open.
4.
2014
M4 muscarinic acetylcholine receptor modulation of associative learning and behavioral flexibility in a novel touchscreen cognitive assessment (845.8).
The FASEB Journal.
28.
2014
Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial.
BMC Psychiatry.
14.
2014
Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management.
European Heart Journal.
35.
2014
-
chapter
-
Computer Aided Identification of Motion Disturbances Related to Parkinson’s Disease.
Springer Nature.
2018
-
dataset
-
Competitive binding and GTP-γ-S activity effects of PTAC and xanomeline on the M1-M5 receptor subtypes..
public-library-of-science.
2015
Description of behaviours and rating scales..
public-library-of-science.
2015
Emesis BuTAC / Domperidone..
public-library-of-science.
2015
Overview of BuTAC related side effects..
public-library-of-science.
2015
-
hide from search
-
Early Nonresponse Determined by the Clinical Global Impressions Scale Predicts Poorer Outcomes in Youth with Schizophrenia Spectrum Disorders Naturalistically Treated with Second-Generation Antipsychotics.
Journal of Child and Adolescent Psychopharmacology.
2013
Increased systemic oxidatively generated DNA and RNA damage in schizophrenia.
Psychiatry Research.
2013
Neuropeptide Y Y5 receptor antagonism causes faster extinction and attenuates reinstatement in cocaine-induced place preference.
Pharmacology Biochemistry and Behavior.
2013
Systemic oxidatively generated DNA/RNA damage in clinical depression: Associations to symptom severity and response to electroconvulsive therapy.
Journal of Affective Disorders.
2013